|
6
|
97
|
5bq8B |
Crystal structure of norrin, a wnt signalling activator, crystal form ii |
|
70
|
299
|
5j3hE |
Human insulin receptor domains l1-cr in complex with peptide s519c16 and 83-7 fv |
|
10
|
138
|
5hk5E |
Structure of the grem2-gdf5 inhibitory complex |
|
2
|
47
|
5itmA |
The structure of truncated histone-like protein |
|
13
|
90
|
5hhvA |
Inhibiting complex il-17a and il-17ra interactions with a linear peptide |
|
13
|
110
|
5hi3A |
Binding site elucidation and structure guided design of macrocyclic il-17a antagonists |
|
70
|
324
|
5hufA |
The crystal structure of hemagglutinin from a/gyrfalcon/washington/41088-6/2014 influenza virus |
|
12
|
55
|
4zxyL |
Factor viia in complex with the inhibitor (2r)-2-[(1-aminoisoquinolin-6-yl)amino]-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaene-3,12-dione |
|
12
|
93
|
5hhxA |
Inhibiting complex il-17a and il-17ra interactions with a linear peptide |
|
11
|
55
|
4zxxL |
Factor viia in complex with the inhibitor n-{3-[(2r)-1-{(2r)-2-[(1-aminoisoquinolin-6-yl)amino]-2-phenylacetyl}pyrrolidin-2-yl]-4-(propan-2-ylsulfonyl)phenyl}acetamide |
|
13
|
55
|
5i46L |
Factor viia in complex with the inhibitor (2r,15r)-2-[(1-aminoisoquinolin-6-yl)amino]-8-fluoro-7-hydroxy-4,15,17-trimethyl-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaene-3,12-dione |
|
15
|
95
|
5hhcA |
Crystal structure of chemically synthesized heterochiral {rfx037 plus vegf-a} protein complex in space group p21/n |
|
3
|
48
|
5itjA |
The structure of histone-like protein |
|
16
|
105
|
5hk5A |
Structure of the grem2-gdf5 inhibitory complex |
|
11
|
108
|
5hi5A |
Binding site elucidation and structure guided design of macrocyclic il-17a antagonists |
|
13
|
91
|
5hi4A |
Binding site elucidation and structure guided design of macrocyclic il-17a antagonists |
|
16
|
96
|
4zffC |
Dual-acting fab 5a12 in complex with vegf |
|
29
|
122
|
5fseB |
2.07 a resolution 1,4-benzoquinone inhibited sporosarcina pasteurii urease |
|
153
|
465
|
5fxwA |
Crystal structure of jmjc domain of human histone demethylase uty in complex with fumarate |
|
154
|
465
|
5fxvA |
Crystal structure of jmjc domain of human histone demethylase uty in complex with n05859b |
|
30
|
122
|
5g4hB |
1.50 a resolution catechol (1,2-dihydroxybenzene) inhibited sporosarcina pasteurii urease |
|
72
|
323
|
5gjtA |
Crystal structure of h1 hemagglutinin from a/washington/05/2011 in complex with a neutralizing antibody 3e1 |
|
155
|
465
|
5fxzA |
Crystal structure of jmjc domain of human histone demethylase uty in complex with citrate |
|
74
|
324
|
5gjsA |
Crystal structure of h1 hemagglutinin from a/california/04/2009 in complex with a neutralizing antibody 3e1 |
|
154
|
465
|
5fxxA |
Crystal structure of jmjc domain of human histone demethylase uty in complex with oxaloacetate |
|
195
|
551
|
4z0lA |
The murine cyclooxygenase-2 complexed with a nido-dicarbaborate-containing indomethacin derivative |
|
152
|
465
|
5fy7A |
Crystal structure of jmjc domain of human histone demethylase uty in complex with succinate |
|
155
|
465
|
5fymA |
Crystal structure of jmjc domain of human histone demethylase uty in complex with d-2-hydroxyglutarate |
|
149
|
465
|
5fy1A |
Crystal structure of jmjc domain of human histone demethylase uty in complex with n08619b |
|
154
|
465
|
5fy0A |
Crystal structure of jmjc domain of human histone demethylase uty in complex with l-malate |
|
13
|
96
|
5fv2V |
Crystal structure of hvegf in complex with vh domain antibody |
|
15
|
85
|
5fwwC |
Wnt modulator kremen in complex with dkk1 (crd2) and lrp6 (pe3pe4) |
|
14
|
95
|
5fv1V |
Crystal structure of hvegf in complex with vk domain antibody |
|
31
|
122
|
5fsdB |
1.75 a resolution 2,5-dihydroxybenzensulfonate inhibited sporosarcina pasteurii urease |
|
149
|
462
|
5fp3A |
Cell penetrant inhibitors of the jmjd2 (kdm4) and jarid1 (kdm5) families of histone lysine demethylases |
|
208
|
553
|
5f1aA |
The crystal structure of salicylate bound to human cyclooxygenase-2 |
|
202
|
552
|
5f19A |
The crystal structure of aspirin acetylated human cyclooxygenase-2 |
|
21
|
129
|
5fo8C |
Crystal structure of human complement c3b in complex with mcp (ccp1-4) |
|
11
|
108
|
5f3hI |
Structure of myostatin in complex with humanized rk35 antibody |
|
12
|
55
|
4z0kB |
Rapid development of two factor ixa inhibitors from hit to lead |
|
207
|
551
|
5fdqA |
Murine cox-2 s530t mutant |
|
13
|
109
|
5f3bC |
Structure of myostatin in complex with chimeric rk35 antibody |
|
71
|
323
|
5e34A |
Crystal structure of h5 hemagglutinin mutant (n224k, q226l, n158d and l133a deletion) from the influenza virus a/chicken/vietnam/ncvd-093/2008 (h5n1) with lsta |
|
76
|
323
|
5e2yA |
Crystal structure of h5 hemagglutinin q226l mutant from the influenza virus a/duck/egypt/10185ss/2010 (h5n1) |
|
13
|
62
|
5ebxA |
The crystal structure of erabutoxin a at 2.0 angstroms resolution |
|
76
|
323
|
5e32A |
Crystal structure of h5 hemagglutinin mutant (n224k, q226l, n158d and l133a deletion) from the influenza virus a/chicken/vietnam/ncvd-093/2008 (h5n1) |
|
12
|
55
|
4zaeB |
Development of a novel class of potent and selective fixa inhibitors |
|
23
|
108
|
5e4gA |
Crystal structure of human growth differentiation factor 11 (gdf-11) |
|
78
|
323
|
5e30A |
Crystal structure of h5 hemagglutinin q226l mutant from the influenza virus a/duck/egypt/10185ss/2010 (h5n1) with lstc |
|
7
|
43
|
5e8dA |
Crystal structure of human epiregulin in complex with the fab fragment of murine monoclonal antibody 9e5 |
